title: Dopaminergic control of renal tubular function in patients with compensated cirrhosis.
abstract: In normal humans, plasma dopamine levels rise during head-out water immersion or saline intravenous infusion. Dopamine inhibits Na+,K+-ATPase activity in the proximal tubule and blunts aldosterone secretion leading to increased diuresis and natriuresis. The aim of this study is to evaluate the role of endogenous dopaminergic activity in the intrarenal sodium handling in patients with compensated liver cirrhosis. We studied nine healthy controls and 12 patients with Child-Pugh A cirrhosis during a normosodic diet for (1) dopaminergic activity, as measured by the incremental aldosterone responses 30 and 60 min after intravenous metoclopramide administration; (2) basal plasma levels of active renin and aldosterone; (3) 4-hr renal clearance of lithium (an index of fluid delivery to the distal tubule), creatinine, sodium, and potassium, first without and then with dopaminergic blockade with intravenous metoclopramide. The patients displayed greater endogenous dopaminergic activity, evidenced by higher incremental aldosterone responses compared with controls (+30 min: 160.2 +/- 68.8 vs 83.6 +/- 35.2 pg/ml, P < 0.01; +60 min: 140.5 +/- 80.3 vs 36.8 +/- 39.1 pg/ml, P < 0.01, respectively). In spite of this, patients and controls did not show significantly different basal aldosterone plasma levels, delivery of sodium to the distal nephron, or urinary excretion of sodium. In both groups the dopaminergic blockade with metoclopramide determined no change in sodium and potassium urinary excretion, but it caused a fall of the fluid and sodium delivery from the proximal tubule to the distal nephron among the patients (from 30.7 +/- 9.3 to 14.4 +/- 4.5 ml/min, P < 0.001; and from 4.25 +/- 1.30 to 2.00 +/- 0.64 meq/min, P < 0.001, respectively). In this group the natriuresis was maintained due to a reduction of the reabsorbed fraction of the distal sodium delivery (from 97.5 +/- 1.9% to 89.8 +/- 12.4%, P < 0.05). In conclusions, compensated cirrhotic patients display an increased endogenous dopaminergic activity compared with controls. This function is critical in maintaining the delivery of sodium to the distal nephron.
authors.affiliation: Gastroenterology Unit, Gradenigo Hospital, Turin, Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Sansoè
authors.forename: Alberto
authors.initials: A
authors.lastname: Ferrari
authors.forename: Enrica
authors.initials: E
authors.lastname: Baraldi
authors.forename: Carmen Nives
authors.initials: CN
authors.lastname: Castellana
authors.forename: Alessandra
authors.initials: A
authors.lastname: Biava
authors.forename: Stefano
authors.initials: S
authors.lastname: Silvano
authors.forename: Floriano
authors.initials: F
authors.lastname: Rosina
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Bonardi
authors.forename: Federico
authors.initials: F
authors.lastname: Manenti
mesh_terms: D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000097:blood; D016022:Case-Control Studies; D004298:Dopamine / Q000502:physiology*; D018492:Dopamine Antagonists / Q000494:pharmacology; D005260:Female; D006801:Humans; D007101:Immersion; D007684:Kidney Tubules / Q000503:physiopathology*; D018021:Lithium Chloride; D008103:Liver Cirrhosis / Q000503:physiopathology*; D008297:Male; D008787:Metoclopramide / Q000494:pharmacology; D008875:Middle Aged; D009318:Natriuresis / Q000502:physiology*; D012964:Sodium / Q000378:metabolism
chemical_list: D018492:Dopamine Antagonists; D000450:Aldosterone; D012964:Sodium; D018021:Lithium Chloride; D008787:Metoclopramide; D004298:Dopamine